$
Federal Contract Award
Emergent Product Development Gaithersburg INC.
Department of Health and Human Services · July 1, 2022 · FY2022
HHSO100201000059CFull & OpenNAICS 541711
Obligated
$8,047,679
Contract details
- Award ID
- CONT_AWD_HHSO100201000059C_7505_-NONE-_-NONE-
- PIID
- HHSO100201000059C
- Period of performance
- September 17, 2010 → June 9, 2022
- Place of performance
- GAITHERSBURG, MD, USA
- Set-aside
- None (Full & Open)
- Pricing type
- COST PLUS FIXED FEE
- PSC
- C118 — RESEARCH AND DEVELOPMENT FACILITIES
- NAICS
- 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Scope
TAS::75 0140::TAS ADVANCED DEVELOPMENT OF RECOMBINANT PROTECTIVE ANTIGENT (RPA) ANTHRAX VACCINE CAN 1990087
Parent vehicle (IDV)
Emergent Biosolutions INC.
UEI M7ZHZ4P2MDG4
This award was placed as a task/delivery order under a larger contract vehicle.
Recipient
Emergent Product Development Gaithersburg INC. →- UEI
- CNPVCR8DK7M8
- CAGE
- 057Y1
- Parent
- Emergent Biosolutions INC.
- Address
- GAITHERSBURG, MD
Awarding agency
Department of Health and Human Services →- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funding agency
- Department of Health and Human Services
- Funding office
- BARDA - ASPR / DAAPPO / BARDA DCMA
See every contract Emergent Product Development Gaithersburg INC. has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Emergent Product Development Gaithersburg INC. profile →